# Real‐world data on the efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-data-on-the-efficacy-and-safety-of-apremilast-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Evangelia Papadavid,Natalia Rompoti,Konstantinos Theodoropoulos,G. Kokkalis,Dimitrios Rigopoulos |
| Citations | 75 |
| DOI | 10.1111/jdv.14832 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2791244279 |
| PMID | 29388335 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Dimitrios Rigopoulos](https://scholariq.org/researchers/dimitrios-rigopoulos/)

## Paper journal

- [Journal of the European Academy of Dermatology and Venereology](https://scholariq.org/journals/journal-of-the-european-academy-of-dermatology-and-venereology/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.